Daniel L. Sheets - 04 Dec 2024 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Dec 2024, 16:26:58 UTC
Prior SEC filing
12 Nov 2024
Next SEC filing
15 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Vincent Donargo, as attorney-in-fact

Key filing fact

Daniel L. Sheets filed Form 4 for Calumet, Inc. /DE (CLMT) on 05 Dec 2024.

Key facts

  • This page summarizes Daniel L. Sheets's Form 4 filing for Calumet, Inc. /DE (CLMT).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Dec 2024, 16:26.

Change

  • Previous filing in this sequence was filed on 12 Nov 2024.
  • Current net transaction value: -$75,377.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLMT transaction

Common Stock, par value $0.01 per share

Options Exercise

Transaction value
$0
Shares
+8,921
Change %
+15%
Price
$0.000000
Shares after
70,393
Date
04 Dec 2024
Ownership
Direct
CLMT transaction

Common Stock, par value $0.01 per share

Sale

Transaction value
$75,377
Shares
-3,569
Change %
-5.1%
Price
$21.12
Shares after
66,824
Date
04 Dec 2024
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLMT transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-8,921
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Dec 2024
Ownership
Direct
Underlying class
Common Stock, par value $0.01 per share
Underlying amount
8,921
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reporting person elected to receive 40% of all Restricted Stock Units vesting in the year ending December 31, 2024 to be settled in the cash equivalent of a Calumet, Inc. common share.

Footnote F2

Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.

Footnote F3

100% of the Restricted Stock Units vested on November 3, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .